Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.
Blood Adv
; 6(10): 3062-3067, 2022 05 24.
Article
in En
| MEDLINE
| ID: mdl-35078224
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2022
Document type:
Article